Biogen(BIIB) · US
Sector: XLV | Last updated: 15 Oct 2026
Biogen (BIIB) is showing Strong Bullish momentum today, with an Altra Score of 89.5 on AltraOne's multi-timeframe (MTF) momentum analysis. The stock is part of the XLV sector, where it ranks 13 by relative strength in a currently bullish RS regime (Relative Strength: 132.14). There are no active EMA crossover signals at the moment. BIIB closed at 235.35 on 15 Oct 2026 (-0.48% for the day), based on end-of-day (EOD) price data rather than a live quote.
Price
Stock Relative Strength
Latest EMA CrossOvers
No active signals
BIIB's Daily RSI(14) is 66.0 (up 2.3 from prior), Weekly RSI is 68.7 (up 4.4 from prior), and Monthly RSI is 81.2 (up 1.9 from prior). Price is currently trading above its Daily EMA 8, Daily EMA 20, Daily EMA 50, Daily EMA 200, Weekly EMA 8, Weekly EMA 30.
Multi-Timeframe RSI (14)
| Timeframe | RSI | Prev | Change |
|---|---|---|---|
| Daily | 66.0 | 63.7 | ▲ 2.3 |
| Weekly | 68.7 | 64.3 | ▲ 4.4 |
| Monthly | 81.2 | 79.3 | ▲ 1.9 |
Stock Price and EMA Placement
History
TradingView ↗The current active signal for BIIB is Bullish, triggered on 19 Sept 2025 at a price of 142.50. Since then, the stock has gained 65.16%.
These are long-term momentum shifts, not buy/sell recommendations.